In the treatment of Wilson's disease, it is sometimes difficult to differentiate side effects due to the drug from those due to the effects of the disease.
- TRADE NAMES: Artamin; D-Penamine; Depen (MedPointe); Distamine; Kelatin; Pendramine
- INDICATIONS: Wilson’s disease, rheumatoid arthritis
- CLASS: Antidote, Chelator, Disease-modifying antirheumatic drug (DMARD)
- HALF-LIFE: 1.7–3.2 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aluminum, Antacids, Ascorbic Acid, Bone marrow suppressants, Chloroquine, Clozapine, Cytotoxic agents, Diclofenac, Ferrous Sulfate, Food, Gold & Gold Compounds, Hydroxychloroquine, Iron, Magnesium, Meloxicam, Primaquine, Probenecid, Sodium Picosulfate
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of D-penicillamine in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 12/26/2024
